<SEC-DOCUMENT>0001127602-15-022124.txt : 20150702
<SEC-HEADER>0001127602-15-022124.hdr.sgml : 20150702
<ACCEPTANCE-DATETIME>20150702135158
ACCESSION NUMBER:		0001127602-15-022124
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150702
FILED AS OF DATE:		20150702
DATE AS OF CHANGE:		20150702

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3215

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Farkas Charles
		CENTRAL INDEX KEY:			0001615538

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16093
		FILM NUMBER:		15968613

	MAIL ADDRESS:	
		STREET 1:		C/O CONMED CORPORATION
		STREET 2:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2015-07-02</periodOfReport>

    <issuer>
        <issuerCik>0000816956</issuerCik>
        <issuerName>CONMED CORP</issuerName>
        <issuerTradingSymbol>CNMD</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001615538</rptOwnerCik>
            <rptOwnerName>Farkas Charles</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CONMED CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>525 FRENCH ROAD</rptOwnerStreet2>
            <rptOwnerCity>UTICA</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>13502</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2015-07-02</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>205</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>58.6552</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3440</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/27/15.</footnote>
        <footnote id="F2">The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $58.64 to $58.67.  Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Daniel S. Jonas for Charles Farkas by Power of Attorney</signatureName>
        <signatureDate>2015-07-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
